Advertisement

Topics

Belgian Biotech Passes Go and May Collect €290M for Arthritis Drug’s Progress

08:53 EDT 31 Jul 2017 | Labiotech.eu

Galapagos has received another tranche of €290M in milestones as Servier exercises its option to develop its osteoarthritis candidate, GLPG1972. Galapagos, the Belgian biotech that made its way onto our list of the largest in Europe, continues to rake in cash from ...

This awesome article Belgian Biotech Passes Go and May Collect €290M for Arthritis Drug’s Progress appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Belgian Biotech Passes Go and May Collect €290M for Arthritis Drug’s Progress

NEXT ARTICLE

More From BioPortfolio on "Belgian Biotech Passes Go and May Collect €290M for Arthritis Drug’s Progress"

Quick Search
Advertisement
 

Relevant Topics

Arthritis
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...